CellZome, created in 2000 (Germany), from 1722 sister brands and 17478 competing brands. CellZome is owned by GSK PLC, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. CellZome belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
GSK PLC
(CellZome)
over 5 years*
GBX 1,583.48